Location History:
- Guangdong, CN (2015)
- Corona, NY (US) (2015 - 2017)
Company Filing History:
Years Active: 2015-2017
Title: Zhi Qi: Innovator in HIV Research
Introduction
Zhi Qi is a prominent inventor based in Corona, NY (US), known for his significant contributions to the field of HIV research. He holds a total of 3 patents, showcasing his innovative approach to developing pharmaceutical compositions aimed at combating HIV.
Latest Patents
Zhi Qi's latest patents include groundbreaking work on stabilized trimeric HIV-1 GP41 fusion inhibitor polypeptides. These patents disclose trimeric polypeptide pharmaceutical compositions that consist of three monomers. Each monomer features a polypeptide with the amino acid sequence of the N-terminal heptad repeat (NHR or HR1) or C-terminal heptad repeat (CHR or HR2) of the transmembrane glycoprotein of HIV, along with a trimerization motif. This innovative approach aims to enhance the efficacy of treatments for HIV.
Career Highlights
Zhi Qi is currently affiliated with the New York Blood Center, Inc., where he continues to advance his research in HIV. His work has been instrumental in developing new therapeutic strategies that could potentially improve patient outcomes.
Collaborations
Zhi Qi collaborates with esteemed colleagues such as Shibo Jiang and Chungen Pan. Their combined expertise contributes to the advancement of research in the field of HIV.
Conclusion
Zhi Qi's innovative work and dedication to HIV research exemplify the impact of inventors in the medical field. His contributions are paving the way for new treatments that could significantly benefit those affected by HIV.